e-learning
resources
Glasgow 2004
Monday 06.09.2004
Drug therapy of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Our experiences in COPD treatment following GOLD implementation in Croatia
B. Butorac Petanjek, D. Vrankovic, D. Pelicaric, M. Krizanic Jurisic, A. Rozman (Zagreb, Croatia)
Source:
Annual Congress 2004 - Drug therapy of COPD
Session:
Drug therapy of COPD
Session type:
Thematic Poster Session
Number:
1867
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Butorac Petanjek, D. Vrankovic, D. Pelicaric, M. Krizanic Jurisic, A. Rozman (Zagreb, Croatia). Our experiences in COPD treatment following GOLD implementation in Croatia. Eur Respir J 2004; 24: Suppl. 48, 1867
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
GOLD recommendations for COPD management
Source: International Congress 2014 – ERS/CTS China Day: advances in asthma and COPD
Year: 2014
Adherence to GOLD guidelines practices in the management of COPD in Tunisia
Source: International Congress 2018 – COPD around the world
Year: 2018
Romanian experience in running COPD awareness campaigns
Source: International Congress 2016 – Public health related concerns and epidemiology of smoking and smoking-related products
Year: 2016
Hospital adherence to GOLD guidelines for COPD exacerbation. Results of the European CODP audit
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
Impact of the GOLD 2011 guidelines on treatment regimens in COPD patients
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
GOLD and phenotypes: The new Czech COPD guidelines
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
COPD: GOLD 2011 and implications for clinical practice
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
The distribution of COPD in UK general practice using the 2017 GOLD classification
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017
Distribution of COPD phenotypes according to the Spanish COPD guidelines in clinical practice
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
High risk COPD patients cost less if treated according to GOLD 2011 recommendations
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Implementation of the GOLD 2017 disease classification in a real-life COPD cohort
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Cost and effectiveness of 2 years integrated care intervention in COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
New GOLD recommendations in a seven years follow up - changes in symptoms and risk categories
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013
Does NICE COPD audit tools affect management of COPD?
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013
The distribution of COPD in UK general practice using the new GOLD classification
Source: Eur Respir J 2014; 43: 993-1002
Year: 2014
Three year follow-up of distribution and stability of patients with COPD according GOLD 2014
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
2 years in the life of COPD patients: Evolution of GOLD 2011 classification in the ’real-life’ DACCORD study
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Rehabilitation programs in patients in different severity stage of COPD (GOLD II-to-IV): analysis of the results
Source: Eur Respir J 2005; 26: Suppl. 49, 69s
Year: 2005
COPD comorbidities and risk assessment according to GOLD 2011 revision
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
Survival in three years of COPD patients according to GOLD 2003 and GOLD 2014
Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept